03:51 PM EST - Valeant Pharmaceuticals International, Inc. : announced first-quarter financial results for 2011. Total revenue was $565.0 million in the first quarter of 2011 as compared to $219.6 million in the first quarter of 2010. The Company reported net income of $6.5 million for the first quarter of 2011, or $0.02 per diluted share. Valeant Pharmaceuticals International, Inc.
shares VRX are trading up $1.05 at $49.72.
